Medicus Pharma Net Profit Margin 1971-1970 | MDCX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Medicus Pharma net profit margin from 1971 to 1970. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Medicus Pharma net profit margin from 1971 to 1970. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$149.5B
Bristol Myers Squibb (BMY)	$121.6B
Vertex Pharmaceuticals (VRTX)	$119.9B
Gilead Sciences (GILD)	$117.2B
CSL (CSLLY)	$88.1B
Regeneron Pharmaceuticals (REGN)	$83.8B
GSK (GSK)	$71.1B
Argenex SE (ARGX)	$37.3B
Alnylam Pharmaceuticals (ALNY)	$32.6B
BioNTech SE (BNTX)	$28.1B
Biogen (BIIB)	$23.9B
Illumina (ILMN)	$23B
BeiGene (BGNE)	$20B
Moderna (MRNA)	$17B
Genmab (GMAB)	$14.5B
Incyte (INCY)	$14.1B
Insmed (INSM)	$13B
BioMarin Pharmaceutical (BMRN)	$12.4B
Sarepta Therapeutics (SRPT)	$12.2B
Bio-Techne Corp (TECH)	$12.1B
Exact Sciences (EXAS)	$11.4B
Vaxcyte (PCVX)	$11.4B
Exelixis (EXEL)	$10.2B
QIAGEN (QGEN)	$10B
Bio-Rad Laboratories (BIO.B)	$9.4B
Intra-Cellular Therapies (ITCI)	$9.1B
Roivant Sciences (ROIV)	$9.1B
Revolution Medicines (RVMD)	$8.7B
Repligen (RGEN)	$8.4B
Ascendis Pharma (ASND)	$8.1B